Sino Biopharmaceutical Limited Share Price
Stocks
1177
KYG8167W1380
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.540 HKD | +0.22% |
|
-6.97% | -26.54% |
| Market Cap | 69.84B 80.78B 10.31B 8.93B 8.19B 7.71B 14.35B 982B 14.58B 97.37B 37.9B 475B 38.71B 37.87B 1,652B | P/E ratio 2026 * |
16.4x | P/E ratio 2027 * | 15.2x |
|---|---|---|---|---|---|
| Enterprise value | 62.97B 72.83B 9.3B 8.05B 7.39B 6.95B 12.94B 886B 13.15B 87.8B 34.17B 428B 34.9B 34.14B 1,490B | EV / Sales 2026 * |
1.75x | EV / Sales 2027 * | 1.48x |
| Free-Float |
49.12% | Yield 2026 * |
2.11% | Yield 2027 * | 2.3% |
| 1 day | +0.22% | ||
| 1 week | -6.97% | ||
| Current month | -9.02% | ||
| 1 month | -19.79% | ||
| 3 months | -26.42% | ||
| 6 months | -33.92% | ||
| Current year | -26.54% |
| 1 week | 4.43 |  | 4.86 |
| 1 month | 4.43 | | 5.83 |
| Current year | 4.43 | | 7.29 |
| 1 year | 4.43 | | 9.12 |
| 3 years | 2.29 | | 9.12 |
| 5 years | 2.29 | | 9.12 |
| 10 years | 2.1 | | 11.24 |
| Manager | Title | Age | Since |
|---|---|---|---|
S Y Tse
CEO | Chief Executive Officer | 30 | 27/07/2022 |
Chun Ling Li
DFI | Director of Finance/CFO | 55 | 31/12/1995 |
Xiao yan Kang
CTO | Chief Tech/Sci/R&D Officer | - | 27/04/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Ping Tse
CHM | Chairman | 74 | 01/02/2000 |
Hsin Tse
BRD | Director/Board Member | 56 | 31/07/1995 |
| Director/Board Member | 62 | 09/04/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 04-28 | Other | Founder | 2,000,000 | 0.0107% | ||
| 04-27 | Other | Founder | 3,000,000 | 0.0160% | ||
| 12-23 | Other | Director | 1,000,000 | 0.0053% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.22% | -6.97% | -4.22% | +17.62% | 10.31B | |
| +1.57% | +6.19% | +49.26% | +157.85% | 1,025B | |
| -0.26% | +3.87% | +49.75% | +44.86% | 559B | |
| -1.83% | +4.76% | +17.51% | +62.07% | 394B | |
| -2.51% | +3.06% | +21.96% | +15.20% | 324B | |
| -1.05% | +3.78% | +51.35% | +8.34% | 295B | |
| -1.83% | +2.26% | +25.44% | +15.37% | 286B | |
| -0.46% | +3.24% | +19.57% | +29.38% | 270B | |
| -1.52% | -3.28% | -48.34% | -50.80% | 186B | |
| -1.10% | +5.04% | +19.08% | +56.61% | 187B | |
| Average | -0.84% | +1.94% | +20.14% | +35.65% | 353.65B | |
| Weighted average by Cap. | -0.38% | +3.98% | +32.39% | +65.69% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 36B 41.64B 5.31B 4.6B 4.22B 3.97B 7.4B 506B 7.52B 50.19B 19.53B 245B 19.95B 19.52B 852B | 39.06B 45.18B 5.77B 4.99B 4.58B 4.31B 8.03B 550B 8.16B 54.47B 21.2B 266B 21.65B 21.18B 924B |
| Net income | 4.17B 4.82B 615M 532M 489M 460M 856M 58.59B 870M 5.81B 2.26B 28.34B 2.31B 2.26B 98.54B | 4.51B 5.21B 665M 576M 529M 497M 926M 63.39B 941M 6.28B 2.45B 30.65B 2.5B 2.44B 107B |
| Net Debt | -6.87B -7.94B -1.01B -878M -805M -758M -1.41B -96.57B -1.43B -9.57B -3.73B -46.7B -3.81B -3.72B -162B | -12.1B -14B -1.79B -1.55B -1.42B -1.34B -2.49B -170B -2.53B -16.87B -6.57B -82.34B -6.71B -6.56B -286B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/06/26 | 4.540 $ | +0.22% | 99,839,073 |
| 08/06/26 | 4.530 $ | -2.79% | 90,451,572 |
| 05/06/26 | 4.660 $ | -0.85% | 82,510,640 |
| 04/06/26 | 4.700 $ | -1.47% | 102,968,100 |
| 03/06/26 | 4.770 $ | -2.25% | 79,359,460 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 1177 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition